Clindamycin phosphate; tretinoin - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for clindamycin phosphate; tretinoin and what is the scope of patent protection?
Clindamycin phosphate; tretinoin
is the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Encube, Solaris Pharma Corp, Almirall, and Bausch, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for clindamycin phosphate; tretinoin
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Clinical Trials: | 9 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for clindamycin phosphate; tretinoin |
DailyMed Link: | clindamycin phosphate; tretinoin at DailyMed |
Recent Clinical Trials for clindamycin phosphate; tretinoin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Alphacait, LLC | Phase 2 |
Zeichner, Joshua, M.D. | Phase 4 |
Pharmacology for clindamycin phosphate; tretinoin
Drug Class | Lincosamide Antibacterial Retinoid |
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Anatomical Therapeutic Chemical (ATC) Classes for clindamycin phosphate; tretinoin
Paragraph IV (Patent) Challenges for CLINDAMYCIN PHOSPHATE; TRETINOIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZIANA | Gel | clindamycin phosphate; tretinoin | 1.2%/0.025% | 050802 | 1 | 2010-12-17 |
US Patents and Regulatory Information for clindamycin phosphate; tretinoin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Encube | CLINDAMYCIN PHOSPHATE AND TRETINOIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 216943-001 | Sep 1, 2023 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Solaris Pharma Corp | CLINDAMYCIN PHOSPHATE AND TRETINOIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 212845-001 | Feb 10, 2022 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Actavis Mid Atlantic | CLINDAMYCIN PHOSPHATE AND TRETINOIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 202564-001 | Jun 12, 2015 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | AB1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Almirall | VELTIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050803-001 | Jul 16, 2010 | AB2 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for clindamycin phosphate; tretinoin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Almirall | VELTIN | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050803-001 | Jul 16, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Sign Up | ⤷ Sign Up |
Bausch | ZIANA | clindamycin phosphate; tretinoin | GEL;TOPICAL | 050802-001 | Nov 7, 2006 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.